Advanced Filters
noise

Montignies-sur-Sambre, Belgium Clinical Trials

A listing of Montignies-sur-Sambre, Belgium clinical trials actively recruiting patients volunteers.

Found 45 clinical trials
H HASCOET SEBASTIEN, PI

European Multicentre Registry of Percutaneous Paravalvular Leak Closure

Paraprosthetic cardiac valve leaks are a progressive complication after after surgical or percutaneous heart valve replacement. These leaks can lead to heart failure and/or life-threatening hemolysis. Percutaneous closure of para-prosthetic leaks has been developed as an alternative to surgery in high-risk patients. These procedures remain technically challenging with a significant …

16 - 110 years of age All Phase N/A

European Registry on the Management of Helicobacter Pylori Infection

The great diversity of regimens and treatment lines, the different efficacy of these, mostly due to the increase in bacterial antibiotic resistance and regional differences, requires a continuous critical analysis of clinical practice, evaluating systematically the efficacy and safety of the different regimens and the cost-effectiveness of the different diagnostic-therapeutic …

18 years of age All Phase N/A
E Esin Er

Alcohol Consumption After Bariatric Surgery

A large body of studies indicate an increase in alcohol use disorder (AUD) rates after bariatric surgery. However, little information exists on the evolution of other drinking patterns after surgery and the psychological predictors of problematic drinking postoperatively. The identification of these factors is necessary for the implementation of prevention …

18 years of age All Phase N/A
M Maude Piron, PhD

Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients

The investigators will collect plasma samples at baseline, during treatment, and at progression.

18 years of age All Phase N/A
D Delphine Pranger, MD

Prospective Observational Study of Diffuse Large-cell B Lymphoma

Diffuse large B-cell lymphoma (DLBCL) represents the most common type of non-Hodgkin lymphoma and is currently a curable malignant disease for many patients with immuno-chemotherapy frontline treatment. However, around 30-40 % of patients, are unresponsive or will experience early relapse. The prognosis of primary refractory patient is poor and the …

18 years of age All Phase N/A

Simplify language using AI